Low bone mineral density (BMD) and osteoporosis are prevalent in HIV-infected patients and were associated with HIV infection and tenofovir-containing ART.
Bianco, C., Rossetti, B., Gagliardini, R., Lamonica, S., Fanti, L., Lombardi, F., Cauda, R., Di Giambenedetto, S., De Luca, A., Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study, Abstract de <<HIV Drug Therapy Glasgow>>, (Glasgow, 02-06 November 2014 ), <<JOURNAL OF THE INTERNATIONAL AIDS SOCIETY>>, 2014; 17 (4 Suppl 3): 19816-19816. 10.7448/IAS.17.4.19816 [http://hdl.handle.net/10807/61163]
Autori: | |
Titolo: | Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study |
Digital Object Identifier (DOI): | http://dx.doi.org/10.7448/IAS.17.4.19816 |
Data di pubblicazione: | 2014 |
Abstract: | Low bone mineral density (BMD) and osteoporosis are prevalent in HIV-infected patients and were associated with HIV infection and tenofovir-containing ART. |
Lingua: | Inglese |
Rivista: | |
Citazione: | Bianco, C., Rossetti, B., Gagliardini, R., Lamonica, S., Fanti, L., Lombardi, F., Cauda, R., Di Giambenedetto, S., De Luca, A., Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study, Abstract de <<HIV Drug Therapy Glasgow>>, (Glasgow, 02-06 November 2014 ), <<JOURNAL OF THE INTERNATIONAL AIDS SOCIETY>>, 2014; 17 (4 Suppl 3): 19816-19816. 10.7448/IAS.17.4.19816 [http://hdl.handle.net/10807/61163] |
Appare nelle tipologie: | Abstract (se pubblicati su rivista) |